Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study

Christian Holm Hansen, Astrid Blicher Schelde, Ida Rask Moustsen-Helm, Hanne-Dorthe Emborg, Tyra Grove Krause, Kåre Mølbak, Palle Valentiner-Branth on behalf of the Infectious Disease Preparedness Group at Statens Serum Institut
doi: https://doi.org/10.1101/2021.12.20.21267966

Article usage

Article usage: December 2021 to November 2023

AbstractFullPdf
Dec 202135683857969157273
Jan 20222026188392085007
Feb 202229532938816244
Mar 20221365736686094
Apr 2022850816513489
May 20227697117012320
Jun 2022578813421837
Jul 2022709829833782
Aug 2022552913422832
Sep 202236718911216
Oct 202231219621377
Nov 20222654694751
Dec 202261626451080
Jan 202326225132210
Feb 20231450399707
Mar 202317392195688
Apr 20231239632339
May 2023995656554
Jun 2023961511672
Jul 2023792245350
Aug 2023885363363
Sep 20231048320458
Oct 2023922265308
Nov 2023636182217
Back to top
Posted December 23, 2021.
Download PDF
Data/Code
Email
Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study
Christian Holm Hansen, Astrid Blicher Schelde, Ida Rask Moustsen-Helm, Hanne-Dorthe Emborg, Tyra Grove Krause, Kåre Mølbak, Palle Valentiner-Branth
medRxiv 2021.12.20.21267966; doi: https://doi.org/10.1101/2021.12.20.21267966
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area